MedTrace Logo

Retrospective Observational Study of Oral Complications and Quality of Life in Head and Neck Cancer Patients Treated With Radiotherapy or Chemoradiotherapy.

NCT07739771 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2026-07-31

No results posted yet for this study

Summary

Head and Neck cancer patients receiving radiation therapy (with or without chemotherapy) suffer several oral complications, such as oral mucositis, which impairs quality of life of patients during radiotherapy and in the post-treatment follow-up period. The use of topical agents to protect oral mucosa against radiation-induced toxicity is part of the routine clinical practice. Among these products, the use of mouthwashes and/or gels are extensively used in the Centro Oncológico Clara Campal - Hospital HM Sanchinarro. Once such product is a proprietary formulation based on natural ingredients such as olive oil, betaine, and xylitol (Mucosa Innovations S.L.).

Conditions

  • Oral Mucositis
  • Quality of Life
  • Mucositis
  • Pain
  • Speech
  • Saliva
  • Radiation Toxicity
  • Chemotherapeutic Toxicity

Sponsors & Collaborators

  • Hospital Universitario HM Sanchinarro - Centro Integral Oncológico Clara Campal

    collaborator UNKNOWN

  • Clínica Vilaboa

    collaborator UNKNOWN

  • Mucosa Innovations, S.L.

    lead INDUSTRY

Principal Investigators

  • Mariola García-Aranda Pez · Hospital Universitario HM Sanchinarro - Centro Integral Oncológico Clara Campal

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07739771 on ClinicalTrials.gov